Patient-specific factors relating to medication adherence in a post-percutaneous coronary intervention cohort

International Journal of Pharmacy Practice

Volumn 20, Issue 4, 2012, Pages 226-237

  Rushworth, Gordon F ^a   Cunningham, Scott ^b   Mort, Alasdair ^c   Rudd, Ian ^d   Leslie, Stephen J ^d,e  

^a Centre for Health Science   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d RAIGMORE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

aspirin; medication adherence; PCI; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; NICORANDIL; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HEALTH BELIEF; HUMAN; INFORMATION PROCESSING; KNOWLEDGE; MALE; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; THERAPEUTIC MISCONCEPTION; VALIDATION STUDY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; COMMUNITY PHARMACY SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACISTS; PHYSICIAN-PATIENT RELATIONS; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PROFESSIONAL ROLE; QUESTIONNAIRES;

EID: 84863642698     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2011.00185.x     Document Type: Article

References (40)

1. Nunes V, et al,. Clinical Guidelines and Evidence Review for Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2009.
2. Horne R,. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130: S65-S72.
3. Lehane E, McCarthy G,. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud 2007; 44: 1468-1477.
4. National Institute for Health and Clinical Excellence. Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence. CG76 ed. London: National Institute for Health and Clinical Excellence, 2009.
5. Lytsy P, Westerling R,. Patient expectations on lipid-lowering drugs. Patient Educ Couns 2007; 67: 143-150. (Pubitemid 46880128)
6. Byrne M, et al,. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res 2005; 58: 403-415. (Pubitemid 40982202)
7. Liu-Seifert H, et al,. Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia. Patient Prefer Adherence 2007; 1: 9-17.
8. Trewby PN, et al,. Are preventative drugs preventative enough? A study of patients' expectation of benefit from preventative drugs. Clin Med 2002; 2: 527-533. (Pubitemid 35477318)
9. Sorensen L, et al,. Laypersons' understanding of relative risk reductions: randomised cross-sectional study. BMC Med Inform Decis Mak 2008; 8: 31-38.
10. Ramstrom H, et al,. Differences in beliefs between patients and pharmaceutical specialists regarding medications. Patient Educ Couns 2006; 62: 244-249. (Pubitemid 43975708)
11. Mardby A, et al,. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 2007; 69: 164.
12. van der Wal MHL, et al,. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 2006; 27: 434-440. (Pubitemid 43209168)
13. Oliver JJ, et al,. Research letter: doctors and the public concord in their acceptance of antihypertensive drug treatment. J Hum Hypertens 2006; 20: 901-903. (Pubitemid 44614075)
14. Furze G,. Cardiac misconceptions-a problem in need of treatment. Pract Cardiovasc Risk Manag 2007; 5: 13-15. (Pubitemid 46142647)
15. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization, 2003.
16. Ho PM, et al,. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J 2007; 154: 846-851. (Pubitemid 350010928)
17. Ho PM, et al,. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. J Am Med Assoc 2008; 299: 532-539. (Pubitemid 351222546)
18. Wenaweser P, et al,. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 2005; 26: 1180-1187. (Pubitemid 40863124)
19. Spertus JA, et al,. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006; 113: 2803-2809. (Pubitemid 44305292)
20. Ko DT, et al,. Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents. Am Heart J 2009; 158: 592-598.
21. Lesaffre E, et al,. A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS. Clin Ther 2003; 25: 2431-2447. (Pubitemid 37267250)
22. Williams AF, et al,. Adherence to multiple, prescribed medications in diabetic kidney disease: a qualitative study of consumers' and health professionals' perspectives. Int J Nurs Stud 2008; 45: 1742-1756.
23. Lehane E, et al,. Medication-taking for coronary artery disease â patients' perspectives. Eur J Cardiovasc Nurs 2008; 7: 133-139. (Pubitemid 351697813)
24. Bennett SJ, et al,. Reliability and validity of the compliance belief scales among patients with heart failure. Heart Lung 2001; 30: 177-185. (Pubitemid 32424297)
25. van der Wal MHL, et al,. Development and testing of the Dutch Heart Failure Knowledge Scale. Eur J Cardiovasc Nurs 2005; 4: 273-277. (Pubitemid 41739763)
26. Wu JR, et al,. Testing the psychometric properties of the Medication Adherence Scale with heart failure. Heart Lung 2008; 37: 334-343.
27. Lahdenperä TS, et al,. Development of a scale to assess the compliance of hypertensive patients. Int J Nurs Stud 2003; 40: 677-684. (Pubitemid 37083499)
28. Ogedegbe G, et al,. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol 2003; 56: 520-529. (Pubitemid 36842909)
29. Schroeder K, et al,. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol 2006; 59: 650-651. (Pubitemid 43732416)
30. Svarstad BL, et al,. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999; 37: 113-124. (Pubitemid 29276860)
31. Wetzels G, et al,. Determinants of poor adherence in hypertensive patients: development and validation of the 'Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire'. Patient Educ Couns 2006; 64: 151-158. (Pubitemid 44772954)
32. Zeller A, et al,. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol 2008; 61: 282-288.
33. Thompson K, et al,. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42: 241-247. (Pubitemid 30216535)
34. Dolder CR, et al,. Brief evaluation of mediation influences and beliefs: development testing of a brief scale for medication adherence. J Clin Psychopharmacol 2004; 24: 404-409. (Pubitemid 38944139)
35. George J, et al,. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). Patient Educ Couns 2006; 64: 50-60. (Pubitemid 44772940)
36. Morisky DE, et al,. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74. (Pubitemid 16125389)
37. Morisky DE, et al,. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348-354.
38. Barbour R,. Introducing Qualitative Research. London: Sage, 2008.
39. Ritchie J, Spencer L,. Qualitative data analysis for applied policy research. In:, Bryman A, Burgess RG, eds. Analyzing Qualitative Data. Oxon: Routledge, 1994: 173-194.
40. The Scottish Government. Establishing Effective Therapeutic Partnerships: A Generic Framework to Underpin the Chronic Medication Service Element of the Community Pharmacy Contract. Edinburgh: Scottish Government, 2009.